Two Sigma Investments LP Acquires 20,949 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Two Sigma Investments LP boosted its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 93.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,338 shares of the company's stock after purchasing an additional 20,949 shares during the period. Two Sigma Investments LP's holdings in Surgery Partners were worth $917,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. KBC Group NV raised its position in shares of Surgery Partners by 66.1% during the fourth quarter. KBC Group NV now owns 3,962 shares of the company's stock worth $84,000 after purchasing an additional 1,577 shares during the period. State of Wyoming grew its holdings in shares of Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after acquiring an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. increased its position in Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after purchasing an additional 465 shares during the last quarter. MeadowBrook Investment Advisors LLC raised its stake in shares of Surgery Partners by 16.6% during the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after purchasing an additional 1,460 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Surgery Partners by 279.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock valued at $228,000 after buying an additional 7,925 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on SGRY shares. Macquarie lowered their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Barclays dropped their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Tuesday, March 25th. Finally, Benchmark reissued a "buy" rating and set a $35.00 target price on shares of Surgery Partners in a research report on Monday, April 21st. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $33.56.

Surgery Partners Stock Performance

Shares of Surgery Partners stock traded down $0.04 on Tuesday, reaching $23.32. The stock had a trading volume of 565,998 shares, compared to its average volume of 1,117,435. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The business's 50-day moving average price is $22.28 and its two-hundred day moving average price is $22.76. The stock has a market cap of $2.99 billion, a P/E ratio of -48.58, a price-to-earnings-growth ratio of 19.21 and a beta of 1.93. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The firm had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm's revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.10 EPS. On average, sell-side analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.